State of Wyoming’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,542
Closed -$49.4K 1756
2023
Q4
$49.4K Buy
7,542
+1,222
+19% +$7.89K 0.01% 1306
2023
Q3
$63.2K Sell
6,320
-3,987
-39% -$43.8K 0.01% 1157
2023
Q2
$128K Buy
10,307
+4,189
+68% +$56.5K 0.04% 664
2023
Q1
$85.7K Buy
+6,118
New +$87.9K 0.03% 862
2022
Q2
Sell
-1,093
Closed -$39K 2043
2022
Q1
$39K Buy
+1,093
New +$36.6K 0.02% 1190
2021
Q4
Sell
-2,733
Closed -$134K 1940
2021
Q3
$134K Sell
2,733
-67
-2% -$3.27K 0.09% 306
2021
Q2
$117K Buy
+2,800
New +$109K 0.07% 389

Other funds holding MRVI

State of Wyoming's MRVI Position: Q1 2024 in Review

State of Wyoming sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 7,542 shares — an estimated $49.4K sold.

State of Wyoming first reported a position in MRVI in Q2 2021 and held it in 7 quarters. The position peaked at $134K in Q3 2021. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

  • State of Wyoming reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
  • State of Wyoming sold 7,542 Maravai LifeSciences shares in Q1 2024, an estimated $49.4K.
  • State of Wyoming first reported a position in Maravai LifeSciences in Q2 2021 and held it in 7 quarters.
  • State of Wyoming's Maravai LifeSciences position peaked at $134K in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on State of Wyoming's 13F filing for Q1 2024, filed 14 May 2024.